Neuro-Oncology: Dual inhibition of MAPK and TORC1 signaling retards development of radiation resistance in pediatric BRAFV600E glioma models (Chen Lab, Zheng, Houghton)
July 1, 2025
Fuyang Li , Kathryn M Bondra , Hanzhou Wang , Dias Kurmashev , Bipasha Mukherjee , Suman Kanji , Amyn A Habib , Yidong Chen , Siyuan Zheng , Sandeep Burma , Peter J Houghton Abstract Background MAPK pathway inhibitors (MAPKi) have shown significant efficacy in treating childhood BRAF-activated brain tumors. For tumors harboring BRAFV600E mutations, the drugs are rarely curative, and patients can become refractory [...]
